The new human papillomavirus (HPV) test has higher sensitivity and specificity than Pap testing for cervical cancer, according to an ideas and opinion piece published online.
A new type of therapy, human papillomavirus (HPV)-targeted adoptive T-cell therapy, shows promise in treating some women with advanced cervical cancer, but side effects were often severe.
Rates of cervical cancer in American women may be higher than previously thought, and the disease may arise most often at an age when adequately screened women are advised to stop screening.
Young women treated with radiation for cervical cancer should begin colorectal cancer screening earlier than traditionally recommended, according to new research.
The approved test specifically identifies HPV 16 and 18, as well as detecting 12 other types of high-risk HPVs using a sample of cervical cells.
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|